Lilly beats forecast, helped by soon-fading Cymbalta

(Reuters) - Eli Lilly and Co reported higher-than-expected quarterly earnings, helped by cost cuts and strong sales of Cymbalta, a depression treatment that will lose patent protection by year end, and the drugmaker raised its full-year profit forecast.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news